TNFA — TNF Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $2.04m
- -$6.48m
Annual cashflow statement for TNF Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.2 | -29.9 | -15.2 | -4 | -23.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.624 | 15.6 | 0.698 | -9.8 | 15.3 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.822 | -5.18 | 2.23 | 0.816 | -0.917 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -11.9 | -19.5 | -12.3 | -13 | -8.98 |
| Other Investing Cash Flow Items | -8.76 | 19.9 | 6.91 | 1.85 | -6.1 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.76 | 19.9 | 6.91 | 1.85 | -6.1 |
| Financing Cash Flow Items | — | — | — | -0.077 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 38.7 | 0.074 | 5.55 | 13.1 | 12.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18 | 0.408 | 0.193 | 1.93 | -2.51 |